Cargando…

Stapedius reflex testing shows altered small muscle function in untreated Pompe patients and improvement after enzyme replacement therapy

Detalles Bibliográficos
Autores principales:	Hilz, M, Hoppe, U, Moeller, S, Köhn, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667110/ http://dx.doi.org/10.1186/1471-2474-14-S2-P5

Ejemplares similares

Can stapedius reflex testing objectively measure muscle function in Pompe patients?
por: Hilz, Max J, et al.
Publicado: (2015)

Cytokines in treated and untreated Pompe patients
por: Karabul, N, et al.
Publicado: (2013)

Enzyme replacement therapy and fatigue in adults with Pompe disease
por: Güngör, Deniz, et al.
Publicado: (2013)

Impact of enzyme replacement therapy on survival in adults with Pompe disease
por: Güngör, Deniz, et al.
Publicado: (2013)

Microtomographic morphometry of the stapedius muscle and its tendon
por: Wojciechowski, Tomasz, et al.
Publicado: (2019)

Successful twin pregnancy in a 38-year-old woman with Pompe disease despite interruption of enzyme replacement therapy (ERT)
por: Tiling, N, et al.
Publicado: (2013)

Automated detection of electrically evoked stapedius reflexes (eSR) during cochlear implantation
por: Weiss, Nora M., et al.
Publicado: (2020)

Pompe disease: the role of MRI
por: Fernández, C Pérez, et al.
Publicado: (2013)

Cognitive outcome of classic infantile Pompe patients receiving enzyme therapy
por: Ebbink, BJ, et al.
Publicado: (2013)

Effects of exercise training in 23 adults with Pompe disease receiving enzyme therapy
por: van den Berg, Linda, et al.
Publicado: (2013)

The Relationship between Electrical Stapedius Reflex Thresholds and Behaviorally Most Comfortable Levels in Experienced Cochlear Implant Users
por: Çiprut, Ayça, et al.
Publicado: (2020)

Antibody formation to enzyme therapy in classic infantile Pompe disease: implications of patient age
por: van Gelder, C, et al.
Publicado: (2013)

The Pompe Registry: tracking Pompe disease symptoms in a broad patient population
por: Byrne, B, et al.
Publicado: (2008)

Enzyme replacement therapy (ERT) in pompe disease
por: Fiumara, Agata
Publicado: (2014)

Pompe practice survey of Canadian (Ontario) rheumatologists
por: Thorne, Carter, et al.
Publicado: (2013)

Pompe disease- experience from South India
por: Lingappa, Lokesh, et al.
Publicado: (2013)

Spectrum of Pompe disease in childhood – The Toronto experience
por: Raiman, J, et al.
Publicado: (2013)

Limitations of muscle biopsy in Pompe disease
por: Vissing, John
Publicado: (2013)

Description of the first two cases of Pompe disease in Bulgaria
por: Tournev, I, et al.
Publicado: (2013)

A higher dose of enzyme therapy in patients with classic infantile Pompe disease seems to improve ventilator-free survival and motor function
por: van Gelder, C, et al.
Publicado: (2013)

Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease
por: Mitja, Jevnikar, et al.
Publicado: (2015)

Walking delay as leading symptom in late-onset Pompe disease
por: Gökce, S, et al.
Publicado: (2013)

Unique fiber phenotype composition and metabolic properties of the stapedius and tensor tympani muscles in the human middle ear
por: Rönnblom, Anton, et al.
Publicado: (2023)

Evaluation of muscle biopsy in late-onset GSDII patients before and after enzyme replacement therapy (ERT)
por: Violano, R, et al.
Publicado: (2013)

Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
por: Prater, Sean N, et al.
Publicado: (2013)

Muscle Proteomic Profile before and after Enzyme Replacement Therapy in Late-Onset Pompe Disease
por: Moriggi, Manuela, et al.
Publicado: (2021)

Development of a disease severity scoring system for patients with Pompe disease
por: Giannini, E, et al.
Publicado: (2008)

Enzyme replacement therapy and antibodies in late-onset Pompe disease
por: Schneider, I., et al.
Publicado: (2014)

S2.2 Enzyme replacement therapy in the infantile-onset Pompe disease
por: Parenti, Giancarlo, et al.
Publicado: (2011)

Teaching tolerance: New approaches to enzyme replacement therapy for Pompe disease
por: Cousens, Leslie P., et al.
Publicado: (2012)

Enzyme Replacement Therapy Can Reverse Pathogenic Cascade in Pompe Disease
por: Meena, Naresh Kumar, et al.
Publicado: (2020)

The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
por: Wenninger, Stephan, et al.
Publicado: (2021)

Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
por: Tarallo, Antonietta, et al.
Publicado: (2021)

Feasibility of DBS screening to identify adult patients with Pompe disease in a neuromuscular clinic population
por: Genge, Angela
Publicado: (2013)

Early untreated juvenile idiopathic arthritis: predictors of outcome
por: Pascoli, L, et al.
Publicado: (2008)

Accessing the stapedius muscle via novel surgical retrofacial approach during cochlear implantation surgery: Intraoperative results on feasibility and safety
por: Guntinas-Lichius, Orlando, et al.
Publicado: (2022)

Enzyme replacement therapy reduces the risk for wheelchair dependency in adult Pompe patients
por: van der Meijden, Jan C., et al.
Publicado: (2018)

Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease()
por: Chien, Yin-Hsiu, et al.
Publicado: (2017)

Standardized nursing management of enzyme replacement therapy for late-onset Pompe disease
por: Tang, Shan, et al.
Publicado: (2021)

Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
por: Fiege, Lina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tvpf4uo5kljada043dqdamhsud